4 results found.
... [Code of Federal Regulations] [Title 21, Volume 6] [Revised as of April 1, 2009] From the U.S. Government Printing Office via GPO Access [CITE: 21CFR522.870] [Page 269] TITLE 21 -FOOD AND DRUGS CHAPTER I -FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) PART 522_IMPLANTATION OR INJECTABLE DOSAGE FORM NEW ANIMAL DRUGS -Table of Contents Sec. 522.870 Etodolac. (a) Specifications. Each milliliter contains 100 milligrams (mg) etodolac. (b) Sponsor. See No. 000856 in Sec. 510.600 of this chapter. (c) Conditions of use in dogs (1) Amount. Administer 4.5 to 6.8 mg / pound (10 to 15 mg / kilogram) body weight as a single, dorsoscapular subcutaneous injection. If needed, the daily dose of etodolac tablets as in Sec. 520.870 of this chapter may be given 24 hours after the injection. (2) Indications for use. For the control of pain and inflammation associated with osteoarthritis. (3) Limitations. Federal ...
URL: http://edocket.access.gpo.gov/cfr_2009/aprqtr/21cfr522.870.htm
... [Code of Federal Regulations] [Title 21, Volume 6] [Revised as of April 1, 2009] From the U.S. Government Printing Office via GPO Access [CITE: 21CFR520.870] [Page 158] TITLE 21 -FOOD AND DRUGS CHAPTER I -FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) PART 520_ORAL DOSAGE FORM NEW ANIMAL DRUGS -Table of Contents Sec. 520.870 Etodolac. (a) Specifications. Each tablet contains 150, 300, or 500 milligrams (mg) of etodolac. (b) Sponsor. See 053501 in Sec. 510.600 (c) of this chapter. (c) [Reserved] (d) Conditions of use (1) Dogs (i) Amount. 10 to 15 mg per kilogram (4.5 to 6.8 mg / pound) of body weight per day. (ii) Indications for use. For the management of pain and inflammation associated with osteoarthritis in dogs. (iii) Limitations. Use once-a-day. Federal law restricts this drug to use by or on the order of a ...
URL: http://edocket.access.gpo.gov/cfr_2009/aprqtr/21cfr520.870.htm
... Detomidine hydrochloride injection. 522.540 Dexamethasone injection. 522.542 Dexamethasone-21-isonicotinate suspension. 522.558 Dexmedetomidine. 522.563 Diatrizoate meglumine and diatrizoate sodium injection. 522.650 Dihydrostreptomycin sulfate injection. 522.690 Dinoprost solution. 522.723 Diprenorphine hydrochloride injection. 522.770 Doramectin. 522.775 Doxapram. 522.778 Doxycycline hyclate. 522.784 Doxylamine succinate injection. 522.800 Droperidol and fentanyl citrate injection. 522.810 Embutramide, chloroquine, and lidocaine solution. 522.812 Enrofloxacin. 522.820 Erythromycin. 522.840 Estradiol. 522.842 Estradiol benzoate and testosterone propionate. 522.850 Estradiol valerate and norgestomet in combination. 522.863 Ethylisobutrazine hydrochloride injection. 522.870 Etodolac. 522.883 Etorphine hydrochloride injection. 522.900 Euthanasia solution. 522.914 Fenprostalene solution. 522.955 Florfenicol. 522.960 Flumethasone implantation or injectable dosage forms. 522.960a Flumethasone suspension. 522.960b Flumethasone acetate injection. 522.960c Flumethasone solution. 522.970 Flunixin. 522.995 Fluprostenol sodium injection. 522.1002 Follicle stimulating hormone. 522.1004 Fomepizole. 522.1010 Furosemide. 522.1020 Gelatin solution. 522.1044 Gentamicin. 522.1066 Glycopyrrolate. 522.1077 Gonadorelin injectable. 522.1078 Gonadorelin diacetate tetrahydrate. 522.1079 Serum gonadotropin and chorionic gonadotropin. 522.1081 Chorionic gonadotropin for injection; chorionic gonadotropin suspension. 522.1085 Guaifenesin sterile powder. 522.1086 Guaifenesin injection ...
URL: http://www.access.gpo.gov/nara/cfr/waisidx_09/21cfr522_09.html
... oral dosage forms. 520.622 Diethylcarbamazine citrate oral dosage forms. 520.622a Diethylcarbamazine citrate tablets. 520.622b Diethylcarbamazine citrate syrup. 520.622c Diethylcarbamazine citrate chewable tablets. 520.622d Diethylcarbamazine citrate capsules. 520.623 Diethylcarbamazine citrate, oxibendazole chewable tablets. 520.645 Difloxacin. 520.666 Dirlotapide. 520.763 Dithiazanine iodide oral dosage forms. 520.763a Dithiazanine iodide tablets. 520.763b Dithiazanine iodide powder. 520.763c Dithiazanine iodide and piperazine citrate suspension. 520.784 Doxylamine succinate tablets. 520.804 Enalapril tablets. 520.812 Enrofloxacin tablets. 520.816 Epsiprantel tablets. 520.823 Erythromycin phosphate. 520.863 Ethylisobutrazine hydrochloride tablets. 520.870 Etodolac. 520.903 Febantel oral dosage forms. 520.903a Febantel paste. 520.903b Febantel suspension. 520.903d Febantel-praziquantel paste. 520.903e Febantel tablets. 520.905 Fenbendazole oral dosage forms. 520.905a Fenbendazole suspension. 520.905b Fenbendazole granules. 520.905c Fenbendazole paste. 520.905d Fenbendazole powder. 520.905e Fenbendazole blocks. 520.928 Firocoxib tablets. 520.930 Firocoxib paste. 520.955 Florfenicol. 520.960 Flumethasone tablets. 520.970 Flunixin oral dosage forms. 520.970a Flunixin meglumine granules. 520.970b Flunixin meglumine paste. 520.980 Fluoxetine. 520.1010 Furosemide. 520.1044 Gentamicin sulfate oral dosage forms. 520.1044a Gentamicin sulfate oral solution. 520.1044b Gentamicin ...
URL: http://www.access.gpo.gov/nara/cfr/waisidx_09/21cfr520_09.html
Title 21 Code of Federal Regulations 
